Global Contract Development and Manufacturing Organizations (CDMOs) Market Growth (Status and Outlook) 2025-2031

Global Contract Development and Manufacturing Organizations (CDMOs) Market Growth (Status and Outlook) 2025-2031

The global Contract Development and Manufacturing Organizations (CDMOs) market size is predicted to grow from US$ 102990 million in 2025 to US$ 186200 million in 2031; it is expected to grow at a CAGR of 10.4% from 2025 to 2031.

A contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.

United States is the largest Contract Development and Manufacturing Organizations (CDMOs) market with about 33% market share. Europe is follower, accounting for about 30% market share.

The key players are Lonza, Catalent, Patheon (Thermo Fisher Scientific), Aenova, Siegfried, Recipharm, Strides Shasun, Piramal, Metrics, AMRI, Famar, WuXi AppTech, Asymchem, Porton, Amatsigroup etc. Top 3 companies occupied about 11% market share.

LPI (LP Information)' newest research report, the “Contract Development and Manufacturing Organizations (CDMOs) Industry Forecast” looks at past sales and reviews total world Contract Development and Manufacturing Organizations (CDMOs) sales in 2024, providing a comprehensive analysis by region and market sector of projected Contract Development and Manufacturing Organizations (CDMOs) sales for 2025 through 2031. With Contract Development and Manufacturing Organizations (CDMOs) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contract Development and Manufacturing Organizations (CDMOs) industry.

This Insight Report provides a comprehensive analysis of the global Contract Development and Manufacturing Organizations (CDMOs) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Contract Development and Manufacturing Organizations (CDMOs) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Contract Development and Manufacturing Organizations (CDMOs) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contract Development and Manufacturing Organizations (CDMOs) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contract Development and Manufacturing Organizations (CDMOs).

This report presents a comprehensive overview, market shares, and growth opportunities of Contract Development and Manufacturing Organizations (CDMOs) market by product type, application, key players and key regions and countries.

Segmentation by Type:
API Development
Manufacturing
Drug Delivery

Segmentation by Application:
Pharmaceutical Company
Biotechnology Company
Generic Company

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lonza
Catalent
Patheon (Thermo Fisher Scientific)
Aenova
Siegfried
Recipharm
Strides Shasun
Piramal
Metrics
AMRI
Famar
WuXi AppTech
Asymchem
Porton
Amatsigroup